Abstract

This study aims to develop quetiapine (QTP)-loaded β-cyclodextrin (β-CD) based co-polymeric thiolated polyethylene glycol-poly(lactic-co-glycolic acid) (t-PEG-PLGA) nanoparticles (QTP@β-CD-t-PEG-PLGA) by transesterification process. As a result, the ex-vivo bioadhesion study shows good bioadhesion because of the thiolation of PEG (t-PEG), which can interrelate through mucin and expand the retention time. In-vitro release study demonstrates the QTP release to 20 h (∼98.76%). Herein, sulfhydryl ligands can form disulfide bonds with cysteine-rich mucus areas that increased the viscosity of mucin and accordingly drug retention. Hence, it can be significant accomplishment for nose to brain drug targeting in psychotic disorder management.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.